Evidence map›Paper›PMID 30478163›Full record

ArticleAntimicrobial agents and chemotherapy2019

Renátó Kovács, Jeanett Holzknecht, Zoltán Hargitai, Csaba Papp, Attila Farkas, Attila Borics, Lilána Tóth, Györgyi Váradi, Gábor K Tóth, Ilona Kovács and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Morphotype-specific susceptibility toMicrobiology spectrum · 2026
    Article
  4. Article
  5. Study on the impact of biofilm formation byFrontiers in cellular and infection microbiology · 2025
    Article
  6. Article
  7. Current Perspectives of Antifungal Therapy: A Special Focus onJournal of fungi (Basel, Switzerland) · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Newly Discovered Antimicrobial Peptide ScyampcinAntimicrobial agents and chemotherapy · 2023
    Article
  13. Article
  14. Antimicrobial Peptides with Anti-International journal of molecular sciences · 2022
    Review
  15. Article
  16. Article
  17. The combination ofBioControl (Dordrecht, Netherlands) · 2022
    Article
  18. Article
  19. Potential of Antifungal Proteins (AFPs) to ControlJournal of fungi (Basel, Switzerland) · 2021
    Article
  20. TheInternational journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Renátó KovácsDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Jeanett HolzknechtDivision of Molecular Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
Zoltán HargitaiDepartment of Pathology, Kenézy Gyula Hospital, University of Debrecen, Debrecen, Hungary.
Csaba PappDepartment of Microbiology, Faculty of Science and Informatics, University of Szeged, Szeged, Hungary.
Attila FarkasInstitute of Plant Biology, Biological Research Centre, Hungarian Academy of Sciences, Szeged, Hungary.
Attila BoricsInstitute of Biochemistry, Biological Research Centre, Hungarian Academy of Sciences, Szeged, Hungary.
Lilána TóthInstitute of Plant Biology, Biological Research Centre, Hungarian Academy of Sciences, Szeged, Hungary.
Györgyi VáradiDepartment of Medical Chemistry, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Gábor K TóthDepartment of Medical Chemistry, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Ilona KovácsDepartment of Pathology, Kenézy Gyula Hospital, University of Debrecen, Debrecen, Hungary.
Sandrine DubracDepartment of Dermatology, Venerology and Allergy, Medical University of Innsbruck, Innsbruck, Austria.
László MajorosDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Florentine MarxDivision of Molecular Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
László GalgóczyInstitute of Plant Biology, Biological Research Centre, Hungarian Academy of Sciences, Szeged, Hungary galgoczi.laszlo@brc.mta.hu.ORCID 0000-0002-6976-8910
HUN-REN Szegedi Biológiai Kutatóközpont · HUUniversity of Debrecen · HUInnsbruck Medical University · ATUniversity of Szeged · HU

Funding

Austrian Science Fund FWF I 1644Austrian Science Fund FWF I 3132
6 · The paper itself

Abstract

As a consequence of emerging numbers of vulvovaginitis cases caused by azole-resistant and biofilm-forming

Indexed as

AnimalsAntifungal AgentsCandidiasis, VulvovaginalDrug Resistance, FungalFemaleFlow CytometryHumansMiceMice, Inbred BALB CMicrobial Sensitivity TestsNeosartoryaAntifungal Agentsantifungal mechanismCandida albicansin vitro cytotoxicityin vitro susceptibilityin vivo murine modelNeosartorya fischeri antifungal protein 2vulvovaginitis

Identifiers

PMID30478163
PMCPMC6355578
OpenAlexW2902923080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.